NCT02061670 - Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Seasonal Allergic RhinitisAsthma

Interventions

BIOLOGICAL

Ragweed-SPIRE

Intradermal injection

BIOLOGICAL

Placebo

Trial Locations (5)

Kanata Allergy Services, Kanata

Kingston General Hospital, Kingston

Cheema Research Inc, Mississauga

Ottawa Allergy Research Corp, Ottawa

Inflamax Research, Toronto